Recruiting

Observational Study

Sponsor:

Emory University

Code:

NCT05873608

Conditions

Hematopoietic and Lymphoid System Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Educational video

Interview

Observation

Study Details

Brief summary:

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Conditions

Hematopoietic and Lymphoid System Neoplasm

Malignant Solid Neoplasm

Study ID

NCT05873608

Start date

Oct 6, 2016

Status verified date

Mar, 2026

Completion date

Nov 17, 2027

Anticipated

Primary completion date

Sep 17, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
  • AIM 4: Any cancer patient

Study Design

Enrollment

125 participants

Anticipated

Allocation

Non randomized

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

other: Interview

Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.

other: Aim 4 tests an educational video

The participants watch a video and their comprehension is tested in a pre and post methodology

Interventions

Educational video

Testing an educational video

Interview

Participate in interview

Observation

Undergo observation

Primary outcome measure

  • Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources [ Time Frame: Up to 4 years ]
  • Qualitatively describe patient reported misunderstandings [ Time Frame: Up to 4 years ]
  • Provider and patient preferences for information to be communicated about immunotherapy [ Time Frame: Up to 4 years ]
  • Correct definition rates (pre- versus post-video) [ Time Frame: Up to 4 years ]

Central Contacts and Locations

Central contacts

Rebecca Pentz, PhD

404-778-5694rpentz@emory.edu

Locations

Emory University Hospital/Winship Cancer Institute

Recruiting

Atlanta, Georgia, United States, 30322

Contacts

Rebecca D. Pentz, PhD

404-778-5694rpentz@emory.edu

Margie Dixon

404-778-4379mddixon@emory.edu

Principal Investigator:

Rebecca D. Pentz, PhD

Atlanta VA Medical Center

Recruiting

Decatur, Georgia, United States, 30033

Contacts

Wayne B. Harris, MD

404-728-7680Wayne.Harris@va.gov

Margie Dixon

404-778-4379mddixon@emory.edu

Principal Investigator:

Wayne B. Harris, MD

More Information

Sponsor

Emory University

Last update posted

Apr 6, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Emory University on 2026-04-06.